Biophage PharmaS.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-11-30
Share capital
1 100 000,00 PLN
Registered address
Mogilska 40, 31-546 Kraków, Poland
Electronic delivery address
AE:PL-56338-42437-JAGHH-24

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 7 days early. All were audited by a statutory auditor.

  • 202513/07/2026
  • 202414/07/2025
  • 202310/07/2024
  • 202205/07/2023
  • 202115/07/2022
  • 202024/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 172.36MedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD -18.02kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 17.67kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 73.70kMedianUSD 133.19kAverageUSD 3.03m

Offer

  • Online casino games
  • Slot machines
  • Jackpot games
  • Roulette
  • Blackjack
  • Baccarat
  • Live dealer games

Trademarks

Biophage Pharma currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2019.

MarkNumberClassesStatusProtected until
Bracelan(word)Z.5017663Not registered –
MarkProtected until
Bracelan(word)–

Authorized Representatives

Sylwia Nizioł – President of the Management Board

Manner of representation

President of the Management Board independently, two members of the management board jointly, or a member of the management board with a commercial proxy.

Supervisory board

Andrzej Nędza – Supervisory Board Member
Elżbieta Bylica – Supervisory Board Member
Katarzyna Pasternak – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2012-12-01.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
May 9, 2014Shareholders' meeting convened

Public aid

6 public aid cases recorded, with a total value of $362,531.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$647
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$50,772
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$523

Competitors

Name
MedappS.A.
SkinlabP.S.A.
EIT Rawmaterials Clc Eastsp. z o.o.
COS LabP.S.A.
IntelliseqS.A.
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.
Medtransfersp. z o.o.
Oncotherics PolandS.A.
Fusiomicasp. z o.o.
Ncage TherapeuticsS.A.

Change history

DateEvent
2017-07-14Share capital change
2015-08-26Address change
2015-07-30PKD change
2012-11-30Entered in the register

FAQ

Last updated: 2026-07-16